Tampa Bay Times

AstraZenec­a shots to resume


South Korea says it will resume AstraZenec­a’s COVID-19 vaccine inoculatio­ns for those between the ages of 30 and 60 years as its health authoritie­s balanced potential risks of the shots against a widening outbreak. The Asian nation temporaril­y suspended the use of the vaccine for those below 60 last week after a 20-year-old health care worker was diagnosed with a blood clot shortly after getting an Astra dose. It followed similar blood clot reports elsewhere, prompting dozens of countries to limit Astra use. “Those under 30 will be excluded from AstraZenec­a vaccine shots,” the Korea Centers for Disease Control and Prevention said in a statement. “It is because we concluded that the benefit from getting vaccinated was not big compared with the risk of rare blood clot.”

Newspapers in English

Newspapers from United States